Protalix BioTherapeutics, Inc.
PLX- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001006281
No open-market purchases or sales by Protalix BioTherapeutics, Inc. insiders were filed in the last 90 days; 101 institutions reported holding it in 13F filings for Q2 2026, worth $33.7M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Protalix BioTherapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- +1 vs. Q3 2024
- Shares held
- 4.40M
- +960.2K (+28.0%) vs. Q3 2024
- Total value
- $8.40M
- +$4.87M (+138.0%) vs. Q3 2024
- New holders
- 8
- 12 more added
- Sold out
- 7
- 8 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PLX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 101 | $33.7M |
| Q1 2026 | 100 | $36.6M |
| Q4 2025 | 83 | $26.8M |
| Q3 2025 | 77 | $31.0M |
| Q2 2025 | 63 | $17.6M |
| Q1 2025 | 63 | $21.0M |
| Q4 2024 | 46 | $8.40M |
| Q3 2024 | 45 | $3.53M |
| Q2 2024 | 66 | $6.60M |
| Q1 2024 | 64 | $12.4M |
| Q4 2023 | 66 | $18.1M |
| Q3 2023 | 61 | $15.2M |
| Q2 2023 | 66 | $17.9M |
| Q1 2023 | 34 | $6.15M |
| Q4 2022 | 26 | $4.87M |
| Q3 2022 | 27 | $3.70M |
| Q2 2022 | 30 | $1.30M |
| Q1 2022 | 32 | $1.29M |
| Q4 2021 | 31 | $2.52M |
| Q3 2021 | 35 | $5.91M |
| Q2 2021 | 33 | $8.71M |
| Q1 2021 | 38 | $39.4M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Protalix BioTherapeutics, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 1,118,000 | $2.10M | 0.00% | +162,100+17.0% | Added |
| Northern Trust Corp | 731,742 | $1.38M | 0.00% | +679,451+1,299.4% | Added |
| Millennium Management LLC | 387,921 | $729.3K | 0.00% | +14,164+3.8% | Added |
| Gsa Capital Partners LLP | 305,749 | $575.0K | 0.04% | −129,464−29.7% | Reduced |
| Stratos Wealth Partners, LTD. | 270,000 | $507.6K | 0.01% | 00.0% | Unchanged |
| BlackRock, Inc. | 224,657 | $422.4K | 0.00% | +45,873+25.7% | Added |
| Bridgeway Capital Management, LLC | 181,400 | $341.0K | 0.01% | −2,390−1.3% | Reduced |
| Morgan Stanley | 170,216 | $320.0K | 0.00% | +127,158+295.3% | Added |
| Citadel Advisors LLC | 145,787 | $274.1K | 0.00% | +54,129+59.1% | Added |
| Jane Street Group, LLC | 113,616 | $213.6K | 0.00% | +67,664+147.2% | Added |
| Marshall Wace, LLP | 101,899 | $191.6K | 0.00% | +101,899 | New |
| Squarepoint Ops LLC | 73,940 | $139.0K | 0.00% | +18,522+33.4% | Added |
| Orin Green Financial, LLC | – | $135.4K | 0.06% | – | – |
| Point72 Asia (Singapore) Pte. Ltd. | 53,507 | $100.6K | 0.03% | +6,434+13.7% | Added |
| Commonwealth Equity Services, LLC | 50,000 | $94.0K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 49,710 | $93.5K | 0.00% | −531−1.1% | Reduced |
| HSBC Holdings PLC | 40,023 | $75.6K | 0.00% | 00.0% | Unchanged |
| Prudential Financial Inc | 36,400 | $68.4K | 0.00% | +36,400 | New |
| Barclays PLC | 34,323 | $64.5K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 34,276 | $64.0K | 0.00% | −9,112−21.0% | Reduced |
| Bank of America Corp | 33,714 | $63.4K | 0.00% | −11,280−25.1% | Reduced |
| Cubist Systematic Strategies, LLC | 29,307 | $55.1K | 0.00% | +5,686+24.1% | Added |
| Capital Performance Advisors LLP | 25,976 | $48.8K | 0.02% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 24,867 | $46.8K | 0.00% | −11,571−31.8% | Reduced |
| Aptus Capital Advisors, LLC | 23,363 | $43.9K | 0.00% | +1,026+4.6% | Added |
| PFG Investments, LLC | 20,730 | $39.0K | 0.00% | +20,730 | New |
| Y-Intercept (Hong Kong) Ltd | 18,818 | $35.4K | 0.00% | +18,818 | New |
| UBS Group AG | 18,178 | $34.2K | 0.00% | +17,886+6,125.3% | Added |
| Lido Advisors, LLC | 15,554 | $29.2K | 0.00% | 00.0% | Unchanged |
| Kestra Advisory Services, LLC | 14,000 | $26.3K | 0.00% | −2,000−12.5% | Reduced |
| Altshuler Shaham Ltd | 12,142 | $22.8K | 0.00% | 00.0% | Unchanged |
| Catalyst Funds Management Pty Ltd | 10,200 | $19.2K | 0.00% | 00.0% | Unchanged |
| Harbour Investment Management LLC | 10,100 | $19.0K | 0.01% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 6,000 | $11.1K | 0.00% | 00.0% | Unchanged |
| Truvestments Capital LLC | 2,458 | $4.62K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 1,595 | $3.00K | 0.00% | 00.0% | Unchanged |
| Lazard Asset Management LLC | 1,255 | $2.00K | 0.00% | +1,255 | New |
| Point72 (DIFC) Ltd | 901 | $1.69K | 0.00% | −10,699−92.2% | Reduced |
| BNP Paribas Arbitrage, SA | 716 | $1.35K | 0.00% | +716 | New |
| Group One Trading, L.P. | 656 | $1.23K | 0.00% | +656 | New |
| Citigroup Inc | 632 | $1.19K | 0.00% | +632 | New |
| Activest Wealth Management | 300 | $564 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 250 | $470 | 0.00% | 00.0% | Unchanged |
| Y.D. More Investments Ltd | 220 | $414 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 200 | $376 | 0.00% | 00.0% | Unchanged |
| SRS Capital Advisors, Inc. | 39 | $74 | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −70,817−100.0% | Sold out |
| Sanctuary Advisors, LLC | 0 | $0 | 0.00% | −37,100−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −35,058−100.0% | Sold out |
| Finivi Inc. | 0 | $0 | 0.00% | −14,544−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −6,000−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −5,055−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −3,414−100.0% | Sold out |